Article
Enhancement of adipocyte differentiation by an insulin-sensitizing agent.
Molecular pharmacology - 1 Feb 1992
Kletzien R F, Clarke S D, Ulrich R G
Abstract excerpt
The thiazolidinediones are a class of novel antidiabetic compounds that enhance the response of target tissues to insulin. Pioglitazone, a thiazolidinedione analog, lowers blood glucose and insulin levels in rodent models of non-insulin-dependent diabetes mellitus. We have studied the effect of pioglitazone on 3T3-L1 cells, a cell line that undergoes differentiation from a preadipocyte fibroblastic morphology to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
